Ramsay Stattman Vela & Price’s GSK GSK Stock Holding History

Ramsay Stattman Vela & Price’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,208	Closed	-$499K	–	79
2022 Q4	$499K	Buy	+14,208	New	+$473K	0.11%	74
2022 Q3	–	Sell	-14,209	Closed	-$773K	–	82
2022 Q2	$773K	Hold	14,209	–	–	0.17%	71
2022 Q1	$774K	Hold	14,209	–	–	0.15%	77
2021 Q4	$783K	Hold	14,209	–	–	0.18%	55
2021 Q3	$679K	Hold	14,209	–	–	0.17%	55
2021 Q2	$707K	Hold	14,209	–	–	0.17%	56
2021 Q1	$634K	Hold	14,209	–	–	0.17%	53
2020 Q4	$654K	Hold	14,209	–	–	0.18%	53
2020 Q3	$669K	Hold	14,209	–	–	0.21%	51
2020 Q2	$724K	Hold	14,209	–	–	0.25%	48
2020 Q1	$673K	Hold	14,209	–	–	0.27%	44
2019 Q4	$835K	Hold	14,209	–	–	0.27%	44
2019 Q3	$758K	Hold	14,209	–	–	0.26%	44
2019 Q2	$711K	Hold	14,209	–	–	0.25%	45
2019 Q1	$742K	Hold	14,209	–	–	0.27%	44
2018 Q4	$679K	Hold	14,209	–	–	0.28%	44
2018 Q3	$713K	Hold	14,209	–	–	0.26%	46
2018 Q2	$716K	Sell	14,209 -4,112	-22%	-$207K	0.28%	43
2018 Q1	$895K	Hold	18,321	–	–	0.36%	40
2017 Q4	$812K	Hold	18,321	–	–	0.32%	44
2017 Q3	$930K	Hold	18,321	–	–	0.39%	41
2017 Q2	$987K	Sell	18,321 -1,352	-7%	-$72.1K	0.43%	37
2017 Q1	$1.04M	Hold	19,673	–	–	0.47%	36
2016 Q4	$947K	Hold	19,673	–	–	0.45%	39
2016 Q3	$1.06M	Hold	19,673	–	–	0.51%	34
2016 Q2	$1.07M	Hold	19,673	–	–	0.53%	34
2016 Q1	$997K	Sell	19,673 -5,120	-21%	-$255K	0.51%	34
2015 Q4	$1.25M	Hold	24,793	–	–	0.63%	35
2015 Q3	$1.19M	Hold	24,793	–	–	0.62%	35
2015 Q2	$1.29M	Hold	24,793	–	–	0.63%	35
2015 Q1	$1.43M	Sell	24,793 -4,320	-15%	-$248K	0.69%	34
2014 Q4	$1.55M	Buy	+29,113	New	+$1.63M	0.73%	36

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ramsay Stattman Vela & Price's GSK Position: Q1 2023 in Review

Ramsay Stattman Vela & Price sold out of GSK (GSK) in Q1 2023, closing a stake of 14,208 shares — an estimated $499K sold.

Ramsay Stattman Vela & Price first reported a position in GSK in Q4 2014 and held it in 32 quarters. The position peaked at $1.55M in Q4 2014. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Ramsay Stattman Vela & Price reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Ramsay Stattman Vela & Price sold 14,208 GSK shares in Q1 2023, an estimated $499K.
Ramsay Stattman Vela & Price first reported a position in GSK in Q4 2014 and held it in 32 quarters.
Ramsay Stattman Vela & Price's GSK position peaked at $1.55M in Q4 2014.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Ramsay Stattman Vela & Price's 13F filing for Q1 2023, filed 28 Apr 2023.